Prospective randomized trials affect the outcomes of intraabdominal infection

Annals of Surgery

Volumn 233, Issue 6, 2001, Pages 859-866

  Merlino, James I ^a   Malangoni, Mark A ^a   Smith, Carolyn M ^a   Lange, Ruth L ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ABDOMINAL INFECTION; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; APPENDICITIS; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; SURVIVAL RATE; TREATMENT FAILURE;

ABDOMEN; ABDOMINAL ABSCESS; ADOLESCENT; ADULT; AGE FACTORS; ANTI-BACTERIAL AGENTS; APPENDICITIS; FEMALE; HUMANS; INFECTION; LENGTH OF STAY; MALE; MIDDLE AGED; PATIENT SELECTION; PERITONITIS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0034989829     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200106000-00017     Document Type: Conference Paper

References (29)

1. The historical development of clinical therapeutic trials
2. The future of controlled clinical trials: Is there an alternative to the randomized controlled trial?
3. APACHE II: A severity of disease classification system
4. Surgical infection stratification system for intra-abdominal infection
5. Prognosis in generalized peritonitis
6. Proposed definitions for diagnosis, severity scoring, stratification, and outcome for trials on intraabdominal infection
7. Surgical Infection Society Intra-abdominal Infection Study: Prospective evaluation of management techniques and outcome
8. Impact of anatomical site on bacteriological and clinical outcome in the management of intra-abdominal infections
9. Guidelines for clinical care: Anti-infective agents for intra-abdominal infection: A Surgical Infection Society policy statement
10. Determinants of organ malfunction and death in patients with intra-abdominal sepsis
11. Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections
12. Antibiotic trials in intra-abdominal infections: A critical evaluation of study design and outcome reporting
13. APACHE II score, abdominal sepsis. A prospective study
14. Prognosis in intra-abdominal infections: Multivariate analysis on 604 patients
15. Intra-abdominal infection and acute renal failure
16. Prognosis and treatment of peritonitis: Do se need new scoring systems?
17. A randomized double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections
18. Treatment of intra-abdominal infections is appropriate with single-agent or combination antibiotic therapy
19. Ethics of clinical trials: The use of placebo
20. The use of controls in the clinical evaluation of cancer therapies
21. Participants in prospective, randomized clinical trials for resected non-small lung cancer have improved survival compared with nonparticipants in such trials
22. Antibiotic treatment for surgical peritonitis
23. Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically ill patients
24. Strengthening experimental design by balancing potentially confounding variable across treatment groups